TABLE 4.
Drugs used in this study
| Drug | Conc. | Mechanism | Reference | Rsp5-dependent sensitivities |
|---|---|---|---|---|
| HU | 0.2M | ribonucleotide reductase dependent inhibition of DNA synthesis | Mulder K W, et al., 2005 | Yes |
| MMS | 0.03% | DNA-damaging alkylating agents | Lundin C, et al., 2005 | No |
| CPT | 40μg/ml | DNA-damaging topoisomerase-I inhibition | Wang LF, et al., 1997 | No |